Hepatic Encephalopathy and Health-Related Quality of Life

Clinics in Liver Disease

Volumn 16, Issue 1, 2012, Pages 159-170

  Bianchi, Giampaolo ^a   Giovagnoli, Marco ^a   Sasdelli, Anna Simona ^a   Marchesini, Giulio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Depression; Health status; Hepatic encephalopathy; Liver cirrhosis

Indexed keywords

ANXIETY; CLINICAL FEATURE; COST BENEFIT ANALYSIS; DEPRESSION; DISEASE SEVERITY; EMOTION; HEALTH STATUS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; NOTTINGHAM EXTENDED ACTIVITIES OF DAILY LIVING SCALE; PREVALENCE; PREVENTIVE MEDICINE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SHORT FORM 36; SICKNESS IMPACT PROFILE; SLEEP DISORDER; SOCIAL INTERACTION; SOCIAL ISOLATION; SURVIVAL; SURVIVAL RATE;

HEPATIC ENCEPHALOPATHY; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84856617439     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2011.12.003     Document Type: Review

References (52)

1. The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998, 28:551-558.
2. Aaronson N.K. Quality of life: what is it? How should it be measured?. Oncology 1998, 2:69-76.
3. Spitzer W.O. State of science 1986: quality of life and functional status as target variables for research. JChronic Dis 1987, 40:465-471.
4. Apolone G., De Carli G., Brunetti M., et al. Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval. Pharmacoeconomics 2001, 19:187-195.
5. Patrick D.L., Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989, 27:S217-S232.
6. Guyatt G.H., Juniper E.F., Walter S.D., et al. Interpreting treatment effects in randomised trials. BMJ 1998, 316:690-693.
7. Lydick E., Epstein R.S. Interpretation of quality of life changes. Qual Life Res 1993, 2(3):221-226.
8. Garratt A., Schmidt L., Mackintosh A., et al. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002, 324:1417.
9. Bergner M., Bobbitt R.A., Carter W.B., et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981, 19:787-805.
10. Hunt S.M., McKenna S.P., McEwen J., et al. Aquantitative approach to perceived health status: a validation study. JEpidemiol Community Health 1980, 34:281-286.
11. Hunt S.M., McEwen J., McKenna S.P. Measuring health status: a new tool for clinicians and epidemiologists. JR Coll Gen Pract 1985, 35:185-188.
12. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
13. Brazier J.E., Harper R., Jones N.M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992, 305:160-164.
14. Younossi Z.M., Guyatt G., Kiwi M., et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45:295-300.
15. Marchesini G., Bianchi G., Amodio P., et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001, 120:170-178.
16. Younossi Z.M., Boparai N., Price L.L., et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001, 96:2199-2205.
17. Arguedas M.R., DeLawrence T.G., McGuire B.M. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003, 48:1622-1626.
18. Martin L.M., Sheridan M.J., Younossi Z.M. The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep 2002, 4:79-83.
19. Ries M.L., Jabbar B.M., Schmitz T.W., et al. Anosognosia in mild cognitive impairment: relationship to activation of cortical midline structures involved in self-appraisal. JInt Neuropsychol Soc 2007, 13:450-461.
20. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
21. Mullen K.D. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007, 25(Suppl 1):11-16.
22. Ortiz M., Jacas C., Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. JHepatol 2005, 42(Suppl):S45-S53.
23. Bajaj J.S. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008, 14:3609-3615.
24. Saxena N., Bhatia M., Joshi Y.K., et al. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002, 22:190-197.
25. Davies M.G., Rowan M.J., Feely J. EEG and event related potentials in hepatic encephalopathy. Metab Brain Dis 1991, 6:175-186.
26. Amodio P., Del Piccolo F., Marchetti P., et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999, 29:1662-1667.
27. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. JHepatol 2001, 34:768-773.
28. Dhiman R.K., Chawla Y.K. Minimal hepatic encephalopathy. Indian J Gastroenterol 2009, 28:5-16.
29. Groeneweg M., Quero J.C., De Bruijn I., et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998, 28:45-49.
30. Groeneweg M., Moerland W., Quero J.C., et al. Screening of subclinical hepatic encephalopathy. JHepatol 2000, 32:748-753.
31. Schomerus H., Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001, 16:37-41.
32. Tan H.H., Lee G.H., Thia K.T., et al. Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study. Singapore Med J 2009, 50:255-260.
33. Wunsch E., Szymanik B., Post M., et al. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 2011, 31:980-984.
34. Amodio P. Health related quality of life and minimal hepatic encephalopathy. It is time to insert 'quality' in health care. JGastroenterol Hepatol 2009, 24:329-330.
35. Cordoba J., Flavia M., Jacas C., et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. JHepatol 2003, 39:231-238.
36. Bao Z.J., Qiu D.K., Ma X., et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007, 13:3003-3008.
37. Schomerus H., Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998, 13:361-377.
38. Quero J.C., Hartmann I.J., Meulstee J., et al. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996, 24:556-560.
39. Stewart C.A., Smith G.E. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007, 4:677-685.
40. Martino M.E., Romero-Vives M., Fernandez-Lorente J., et al. Sleep electroencephalogram alterations disclose initial stage of encephalopathy. Methods Find Exp Clin Pharmacol 2002, 24(Suppl D):119-122.
41. Blei A.T., Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 2001, 96:1968-1976.
42. Bianchi G., Marchesini G., Nicolino F., et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis 2005, 37:593-600.
43. Montagnese S., Middleton B., Skene D.J., et al. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver Int 2009, 29:1372-1382.
44. Cordoba J., Cabrera J., Lataif L., et al. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998, 27:339-345.
45. Mostacci B., Ferlisi M., Baldi Antognini A., et al. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci 2008, 29:237-240.
46. Wiltfang J., Nolte W., Weissenborn K., et al. Psychiatric aspects of portal-systemic encephalopathy. Metab Brain Dis 1998, 13:379-389.
47. Wells K.B., Stewart A., Hays R.D., et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989, 262:914-919.
48. Prasad S., Dhiman R.K., Duseja A., et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007, 45:549-559.
49. Sidhu S.S., Goyal O., Mishra B.P., et al. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011, 106:307-316.
50. Bajaj J.S., Saeian K., Christensen K.M., et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008, 103:1707-1715.
51. Ong J.P., Oehler G., Kruger-Jansen C., et al. Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. Clin Drug Investig 2011, 31:213-220.
52. Malaguarnera M., Bella R., Vacante M., et al. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 2011, 46:750-759.